FDA / 2026

Bulk substances that may present significant safety risks: LL-37

Bulk substances that may present significant safety risks — U.S. FDA (2026), cited in PeptideAgent's LL-37 evidence record.

Open original source

SOURCE METADATA

What this record represents.

Publisher
U.S. FDA
Evidence type
FDA
Publication year
2026
Source ID
fda-ll37-risk

WHERE THIS IS CITED

Connected evidence records.

LL-37Native peptide · Immune / Inflammation